<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00973349</url>
  </required_header>
  <id_info>
    <org_study_id>V112_01</org_study_id>
    <nct_id>NCT00973349</nct_id>
  </id_info>
  <brief_title>Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults</brief_title>
  <official_title>A Pivotal Randomized, Single-Blind, Dose-Finding Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and Non-Adjuvanted Egg-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Adult Subjects 18 or More Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novartis Vaccines</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and immunogenicity of different combinations of A/H1N1
      S-OIV (swine flu) vaccine in non-elderly and elderly adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immunogenicity Results After Each Vaccination by Vaccine Group, in Participants 18 to 64 Years of Age</measure>
    <time_frame>21 days after each vaccination</time_frame>
    <description>Seroconversion is defined by CBER (Center for Biologics Evaluation, Research and Review) as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Immunogenicity Results After Each Vaccination by Vaccine Group, in Participants ≥65 Years of Age</measure>
    <time_frame>21 days after each vaccination</time_frame>
    <description>Seroconversion is defined by CBER as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean HI Titer by Vaccine Groups; in Participants 18 to 64 Years of Age and ≥65 Years of Age</measure>
    <time_frame>21 days after each vaccination</time_frame>
    <description>Geometric mean hemagglutinin inhibition (HI) titer = GMT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Seroconversion and With HI ≥1:40, in Participants 18 to 60 Years of Age</measure>
    <time_frame>21 days after each vaccination</time_frame>
    <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP (Committee for Medicinal Products for Human Use) criteria. Seroconversion is defined as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as Hemagglutinin Inhibition (HI) antibody titer ≥1:40.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Seroconversion and With HI ≥1:40, in Participants ≥61 Years of Age</measure>
    <time_frame>21 days after each vaccination</time_frame>
    <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP criteria. Seroconversion is defined as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as Hemagglutinin Inhibition (HI) antibody titer ≥1:40.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Ratio From Baseline, in Participants 18 to 60 Years of Age and ≥61 Years of Age</measure>
    <time_frame>21 days after vaccination</time_frame>
    <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP criteria. Geometric Mean Ratio (GMR) of the hemagglutinin inhibition (HI)titers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Solicited Local and Systemic Reactions After the First Vaccination, in Participants 18 to 64 Years of Age</measure>
    <time_frame>7 days after vaccination</time_frame>
    <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Solicited Local and Systemic Reactions After the Second Vaccination, in Participants 18 to 64 Years of Age</measure>
    <time_frame>7 days after vaccination</time_frame>
    <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Solicited Local and Systemic Reactions After the First Vaccination, in Participants ≥65 Years of Age</measure>
    <time_frame>7 days after vaccination</time_frame>
    <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Solicited Local and Systemic Reactions After the Second Vaccination, in Participants ≥65 Years of Age</measure>
    <time_frame>7 days after vaccination</time_frame>
    <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">2719</enrollment>
  <condition>Influenza</condition>
  <arm_group>
    <arm_group_label>3.75_(50)MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50% of MF59 with 3.75 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7.5 w/o MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0% of MF59 with 7.5 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7.5_(50)MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50% of MF59 with 7.5 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7.5_(100)MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100% of MF59 with 7.5 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15 w/o MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0% of MF59 with 15 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15_(50)MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50% of MF59 with 15 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15_(100)MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100% of MF59 with 15 µg A/H1N1 antigen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30 w/o MF59</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0% of MF59 with 30 µg A/H1N1 antigen</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MF59-eH1N1_f</intervention_name>
    <description>8 arms consisting of different antigen combinations of A/H1N1 S-OIV and different percentages of MF59 adjuvant</description>
    <arm_group_label>3.75_(50)MF59</arm_group_label>
    <arm_group_label>7.5 w/o MF59</arm_group_label>
    <arm_group_label>7.5_(50)MF59</arm_group_label>
    <arm_group_label>7.5_(100)MF59</arm_group_label>
    <arm_group_label>15 w/o MF59</arm_group_label>
    <arm_group_label>15_(50)MF59</arm_group_label>
    <arm_group_label>15_(100)MF59</arm_group_label>
    <arm_group_label>30 w/o MF59</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults 18 years of age and older in good health as determined by medical history,
             physical assessment and clinical judgement of the investigator and without influenza
             within the past 6 months.

        Exclusion Criteria:

          -  History of serious disease.

          -  History of serious reaction following administration of vaccine or hypersensitivity to
             vaccine components.

          -  Known or suspected impairment/alteration of immune function.

          -  Receipt or planned receipt of seasonal trivalent influenza vaccine within 1 week
             before or after each study vaccination.

          -  Sexually active women of childbearing potential must use acceptable birth control
             during the treatment phase of the study.

          -  For additional entry criteria, please refer to protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Vaccine and Diagnostics</last_name>
    <role>Study Director</role>
    <affiliation>Novartis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johnson County Clin-Trials</name>
      <address>
        <city>Lenexa</city>
        <state>Kansas</state>
        <zip>66219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Clinical Research</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Research</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rochester Clinical Research, Inc</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Medical Research Associates</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Medical Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Medical Trials</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prestige Clinical Research</name>
      <address>
        <city>Franklin</city>
        <state>Ohio</state>
        <zip>45005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IPS Research</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Ridge Family Practice (adult)</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Physicians Research Inc. (adult)</name>
      <address>
        <city>Jefferson Hills</city>
        <state>Pennsylvania</state>
        <zip>15025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omega Clinical Research</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02886</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Across America</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Houston Clinical Research Service</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J.Lewis Research, Inc./Foothill Family Clinic</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J. Lewis Research, Inc./Foothill Family Clinic South</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PI-Coor Clinical Research</name>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PI Coor Clinical Research</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias</name>
      <address>
        <city>Tlalpan</city>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2009</study_first_submitted>
  <study_first_submitted_qc>September 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2009</study_first_posted>
  <results_first_submitted>December 7, 2010</results_first_submitted>
  <results_first_submitted_qc>April 21, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 25, 2011</results_first_posted>
  <last_update_submitted>October 29, 2015</last_update_submitted>
  <last_update_submitted_qc>October 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Swine Flu</keyword>
  <keyword>Flu</keyword>
  <keyword>Vaccine</keyword>
  <keyword>Adults</keyword>
  <keyword>Elderly</keyword>
  <keyword>Non-Elderly</keyword>
  <keyword>Adjuvant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>MF59 oil emulsion</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled at 21 sites in the US.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>3.75_(50)MF59 (18-64 Years)</title>
          <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
        </group>
        <group group_id="P2">
          <title>7.5 w/o MF59 (18-64 Years)</title>
          <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
        </group>
        <group group_id="P3">
          <title>7.5_(50)MF59 (18-64 Years)</title>
          <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P4">
          <title>7.5_(100)MF59 (18-64 Years)</title>
          <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P5">
          <title>15 w/o MF59 (18-64 Years)</title>
          <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
        </group>
        <group group_id="P6">
          <title>15_(50)MF59 (18-64 Years)</title>
          <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P7">
          <title>15_(100)MF59 (18-64 Years)</title>
          <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P8">
          <title>30 w/o MF59(18-64 Years)</title>
          <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
        </group>
        <group group_id="P9">
          <title>3.75_(50)MF59 (≥ 65 Years)</title>
          <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
        </group>
        <group group_id="P10">
          <title>7.5 w/o MF59 (≥ 65 Years)</title>
          <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
        </group>
        <group group_id="P11">
          <title>7.5_(50)MF59 (≥ 65 Years)</title>
          <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P12">
          <title>7.5_(100)MF59 (≥ 65 Years)</title>
          <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P13">
          <title>15 w/o MF59 (≥ 65 Years)</title>
          <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
        </group>
        <group group_id="P14">
          <title>15_(50)MF59 (≥ 65 Years)</title>
          <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P15">
          <title>15_(100)MF59 (≥ 65 Years)</title>
          <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
        </group>
        <group group_id="P16">
          <title>30 w/o MF59(≥ 65 Years)</title>
          <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="170"/>
                <participants group_id="P2" count="168"/>
                <participants group_id="P3" count="171"/>
                <participants group_id="P4" count="168"/>
                <participants group_id="P5" count="170"/>
                <participants group_id="P6" count="169"/>
                <participants group_id="P7" count="174"/>
                <participants group_id="P8" count="169"/>
                <participants group_id="P9" count="171"/>
                <participants group_id="P10" count="169"/>
                <participants group_id="P11" count="174"/>
                <participants group_id="P12" count="169"/>
                <participants group_id="P13" count="169"/>
                <participants group_id="P14" count="171"/>
                <participants group_id="P15" count="170"/>
                <participants group_id="P16" count="167"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="166"/>
                <participants group_id="P2" count="165"/>
                <participants group_id="P3" count="166"/>
                <participants group_id="P4" count="163"/>
                <participants group_id="P5" count="165"/>
                <participants group_id="P6" count="165"/>
                <participants group_id="P7" count="172"/>
                <participants group_id="P8" count="166"/>
                <participants group_id="P9" count="167"/>
                <participants group_id="P10" count="163"/>
                <participants group_id="P11" count="174"/>
                <participants group_id="P12" count="167"/>
                <participants group_id="P13" count="168"/>
                <participants group_id="P14" count="171"/>
                <participants group_id="P15" count="168"/>
                <participants group_id="P16" count="165"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="4"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="6"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="2"/>
                <participants group_id="P16" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="2"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inappropriate enrolment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable to classify</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>ITT population for immunology assessments. Participants from one center excluded for GCP issues.</population>
      <group_list>
        <group group_id="B1">
          <title>3.75_(50)MF59 (18 to 64)</title>
          <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B2">
          <title>7.5 w/o MF59 (18 to 64)</title>
          <description>1 dose of 7.5 µg A/H1N1 in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B3">
          <title>7.5_(50)MF59 (18 to 64)</title>
          <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B4">
          <title>7.5_(100)MF59 (18 to 64)</title>
          <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B5">
          <title>15 w/o MF59 (18 to 64)</title>
          <description>1 dose of 15 µg A/H1N1 in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B6">
          <title>15_(50)MF59 (18 to 64)</title>
          <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B7">
          <title>15_(100)MF59 (18 to 64)</title>
          <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen</description>
        </group>
        <group group_id="B8">
          <title>30 w/o MF59 (18 to 64)</title>
          <description>1 dose of 30 µg A/H1N1 in subjects 18 to 64 years of age</description>
        </group>
        <group group_id="B9">
          <title>3.75_(50)MF59 (≥ 65 )</title>
          <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B10">
          <title>7.5 w/o MF59 (≥ 65)</title>
          <description>1 dose of 7.5 µg A/H1N1 in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B11">
          <title>7.5_(50)MF59 (≥ 65)</title>
          <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B12">
          <title>7.5_(100)MF59 (≥ 65)</title>
          <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B13">
          <title>15 w/o MF59 (≥ 65)</title>
          <description>1 dose of 15 µg A/H1N1 in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B14">
          <title>15_(50)MF59 (≥ 65)</title>
          <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B15">
          <title>15_(100)MF59 (≥ 65)</title>
          <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B16">
          <title>30 w/o MF59 (≥ 65)</title>
          <description>1 dose of 30 µg A/H1N1 in subjects ≥ 65 years of age</description>
        </group>
        <group group_id="B17">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="155"/>
            <count group_id="B2" value="153"/>
            <count group_id="B3" value="157"/>
            <count group_id="B4" value="153"/>
            <count group_id="B5" value="155"/>
            <count group_id="B6" value="154"/>
            <count group_id="B7" value="159"/>
            <count group_id="B8" value="154"/>
            <count group_id="B9" value="170"/>
            <count group_id="B10" value="168"/>
            <count group_id="B11" value="172"/>
            <count group_id="B12" value="168"/>
            <count group_id="B13" value="168"/>
            <count group_id="B14" value="171"/>
            <count group_id="B15" value="169"/>
            <count group_id="B16" value="166"/>
            <count group_id="B17" value="2592"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.3" spread="12.8"/>
                    <measurement group_id="B2" value="39.8" spread="12.9"/>
                    <measurement group_id="B3" value="39.1" spread="13.5"/>
                    <measurement group_id="B4" value="40.6" spread="12.2"/>
                    <measurement group_id="B5" value="41.8" spread="12.9"/>
                    <measurement group_id="B6" value="39.7" spread="13.1"/>
                    <measurement group_id="B7" value="38.8" spread="11.9"/>
                    <measurement group_id="B8" value="40.8" spread="13.0"/>
                    <measurement group_id="B9" value="70.8" spread="5.1"/>
                    <measurement group_id="B10" value="71.8" spread="5.6"/>
                    <measurement group_id="B11" value="71.4" spread="5.6"/>
                    <measurement group_id="B12" value="70.7" spread="5.1"/>
                    <measurement group_id="B13" value="71.0" spread="5.0"/>
                    <measurement group_id="B14" value="70.4" spread="4.9"/>
                    <measurement group_id="B15" value="71.3" spread="5.2"/>
                    <measurement group_id="B16" value="70.8" spread="5.3"/>
                    <measurement group_id="B17" value="39.6" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Male(18 to 64 or ≥65 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="59"/>
                    <measurement group_id="B5" value="57"/>
                    <measurement group_id="B6" value="69"/>
                    <measurement group_id="B7" value="71"/>
                    <measurement group_id="B8" value="63"/>
                    <measurement group_id="B9" value="54"/>
                    <measurement group_id="B10" value="88"/>
                    <measurement group_id="B11" value="71"/>
                    <measurement group_id="B12" value="70"/>
                    <measurement group_id="B13" value="68"/>
                    <measurement group_id="B14" value="74"/>
                    <measurement group_id="B15" value="79"/>
                    <measurement group_id="B16" value="76"/>
                    <measurement group_id="B17" value="1079"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female(18 to 64 or ≥65 yrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="94"/>
                    <measurement group_id="B5" value="98"/>
                    <measurement group_id="B6" value="85"/>
                    <measurement group_id="B7" value="88"/>
                    <measurement group_id="B8" value="91"/>
                    <measurement group_id="B9" value="116"/>
                    <measurement group_id="B10" value="80"/>
                    <measurement group_id="B11" value="101"/>
                    <measurement group_id="B12" value="98"/>
                    <measurement group_id="B13" value="100"/>
                    <measurement group_id="B14" value="97"/>
                    <measurement group_id="B15" value="90"/>
                    <measurement group_id="B16" value="90"/>
                    <measurement group_id="B17" value="1513"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Immunogenicity Results After Each Vaccination by Vaccine Group, in Participants 18 to 64 Years of Age</title>
        <description>Seroconversion is defined by CBER (Center for Biologics Evaluation, Research and Review) as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.</description>
        <time_frame>21 days after each vaccination</time_frame>
        <population>The analysis was based on the per protocol population.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Immunogenicity Results After Each Vaccination by Vaccine Group, in Participants 18 to 64 Years of Age</title>
          <description>Seroconversion is defined by CBER (Center for Biologics Evaluation, Research and Review) as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.</description>
          <population>The analysis was based on the per protocol population.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="146"/>
                <count group_id="O2" value="142"/>
                <count group_id="O3" value="142"/>
                <count group_id="O4" value="141"/>
                <count group_id="O5" value="141"/>
                <count group_id="O6" value="138"/>
                <count group_id="O7" value="149"/>
                <count group_id="O8" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Seroprotection Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                    <measurement group_id="O2" value="126"/>
                    <measurement group_id="O3" value="135"/>
                    <measurement group_id="O4" value="134"/>
                    <measurement group_id="O5" value="133"/>
                    <measurement group_id="O6" value="135"/>
                    <measurement group_id="O7" value="147"/>
                    <measurement group_id="O8" value="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="123"/>
                    <measurement group_id="O4" value="126"/>
                    <measurement group_id="O5" value="127"/>
                    <measurement group_id="O6" value="124"/>
                    <measurement group_id="O7" value="135"/>
                    <measurement group_id="O8" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="138"/>
                    <measurement group_id="O2" value="133"/>
                    <measurement group_id="O3" value="136"/>
                    <measurement group_id="O4" value="137"/>
                    <measurement group_id="O5" value="135"/>
                    <measurement group_id="O6" value="137"/>
                    <measurement group_id="O7" value="145"/>
                    <measurement group_id="O8" value="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                    <measurement group_id="O2" value="104"/>
                    <measurement group_id="O3" value="123"/>
                    <measurement group_id="O4" value="129"/>
                    <measurement group_id="O5" value="126"/>
                    <measurement group_id="O6" value="125"/>
                    <measurement group_id="O7" value="139"/>
                    <measurement group_id="O8" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 202 (N=79,65,78,80,73,74,74,76)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="67"/>
                    <measurement group_id="O4" value="70"/>
                    <measurement group_id="O5" value="56"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="65"/>
                    <measurement group_id="O8" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 202 (N=79,65,78,80,73,74,74,76)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="53"/>
                    <measurement group_id="O5" value="49"/>
                    <measurement group_id="O6" value="49"/>
                    <measurement group_id="O7" value="51"/>
                    <measurement group_id="O8" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 387(N=105,95,88,84,91,91,106,84</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                    <measurement group_id="O2" value="78"/>
                    <measurement group_id="O3" value="66"/>
                    <measurement group_id="O4" value="67"/>
                    <measurement group_id="O5" value="66"/>
                    <measurement group_id="O6" value="74"/>
                    <measurement group_id="O7" value="89"/>
                    <measurement group_id="O8" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day387(N=105,95,88,84,91,91,106,84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="53"/>
                    <measurement group_id="O5" value="58"/>
                    <measurement group_id="O6" value="62"/>
                    <measurement group_id="O7" value="71"/>
                    <measurement group_id="O8" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean HI Titer by Vaccine Groups; in Participants 18 to 64 Years of Age and ≥65 Years of Age</title>
        <description>Geometric mean hemagglutinin inhibition (HI) titer = GMT</description>
        <time_frame>21 days after each vaccination</time_frame>
        <population>The analysis was on the per protocol set. For this analysis, total subjects enrolled were stratified and randomized in two age groups, according to the CBER criteria, 18 to 64 years and over 64 years of age.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean HI Titer by Vaccine Groups; in Participants 18 to 64 Years of Age and ≥65 Years of Age</title>
          <description>Geometric mean hemagglutinin inhibition (HI) titer = GMT</description>
          <population>The analysis was on the per protocol set. For this analysis, total subjects enrolled were stratified and randomized in two age groups, according to the CBER criteria, 18 to 64 years and over 64 years of age.</population>
          <units>Geometric Mean Titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="296"/>
                <count group_id="O2" value="289"/>
                <count group_id="O3" value="306"/>
                <count group_id="O4" value="289"/>
                <count group_id="O5" value="300"/>
                <count group_id="O6" value="293"/>
                <count group_id="O7" value="303"/>
                <count group_id="O8" value="294"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 22(18-64yrs;N=146,142,142,141,141,138,149,144)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="299" lower_limit="234" upper_limit="382"/>
                    <measurement group_id="O2" value="238" lower_limit="185" upper_limit="306"/>
                    <measurement group_id="O3" value="379" lower_limit="295" upper_limit="486"/>
                    <measurement group_id="O4" value="551" lower_limit="429" upper_limit="708"/>
                    <measurement group_id="O5" value="536" lower_limit="417" upper_limit="689"/>
                    <measurement group_id="O6" value="538" lower_limit="418" upper_limit="693"/>
                    <measurement group_id="O7" value="677" lower_limit="530" upper_limit="864"/>
                    <measurement group_id="O8" value="637" lower_limit="497" upper_limit="817"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 43(18-64yrs;N=146,142,142,141,141,138,149,144)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="327" lower_limit="262" upper_limit="409"/>
                    <measurement group_id="O2" value="239" lower_limit="198" upper_limit="299"/>
                    <measurement group_id="O3" value="359" lower_limit="286" upper_limit="449"/>
                    <measurement group_id="O4" value="538" lower_limit="429" upper_limit="675"/>
                    <measurement group_id="O5" value="412" lower_limit="328" upper_limit="517"/>
                    <measurement group_id="O6" value="494" lower_limit="393" upper_limit="621"/>
                    <measurement group_id="O7" value="618" lower_limit="496" upper_limit="771"/>
                    <measurement group_id="O8" value="497" lower_limit="397" upper_limit="622"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22 (≥65 yrs;N=150,147,164,148,159,155,154,150)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="138" lower_limit="107" upper_limit="178"/>
                    <measurement group_id="O2" value="133" lower_limit="103" upper_limit="172"/>
                    <measurement group_id="O3" value="146" lower_limit="114" upper_limit="185"/>
                    <measurement group_id="O4" value="184" lower_limit="143" upper_limit="238"/>
                    <measurement group_id="O5" value="187" lower_limit="146" upper_limit="238"/>
                    <measurement group_id="O6" value="203" lower_limit="159" upper_limit="261"/>
                    <measurement group_id="O7" value="252" lower_limit="197" upper_limit="324"/>
                    <measurement group_id="O8" value="237" lower_limit="184" upper_limit="305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 43 (≥65 yrs;N=150,147,164,148,159,155,154,150)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135" lower_limit="107" upper_limit="171"/>
                    <measurement group_id="O2" value="118" lower_limit="93" upper_limit="149"/>
                    <measurement group_id="O3" value="131" lower_limit="104" upper_limit="164"/>
                    <measurement group_id="O4" value="167" lower_limit="132" upper_limit="212"/>
                    <measurement group_id="O5" value="151" lower_limit="120" upper_limit="190"/>
                    <measurement group_id="O6" value="164" lower_limit="130" upper_limit="207"/>
                    <measurement group_id="O7" value="240" lower_limit="190" upper_limit="302"/>
                    <measurement group_id="O8" value="211" lower_limit="167" upper_limit="267"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>1.265</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.998</ci_lower_limit>
            <ci_upper_limit>1.603</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.999</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.791</ci_lower_limit>
            <ci_upper_limit>1.262</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.708</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.558</ci_lower_limit>
            <ci_upper_limit>0.897</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.861</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.681</ci_lower_limit>
            <ci_upper_limit>1.089</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.754</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.596</ci_lower_limit>
            <ci_upper_limit>0.956</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.548</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.434</ci_lower_limit>
            <ci_upper_limit>0.693</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.646</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.510</ci_lower_limit>
            <ci_upper_limit>0.817</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at 43</param_type>
            <param_value>0.790</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.625</ci_lower_limit>
            <ci_upper_limit>1.000</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at 43</param_type>
            <param_value>0.560</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.441</ci_lower_limit>
            <ci_upper_limit>0.710</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at 43</param_type>
            <param_value>0.681</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.538</ci_lower_limit>
            <ci_upper_limit>0.862</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at 43</param_type>
            <param_value>0.597</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.470</ci_lower_limit>
            <ci_upper_limit>0.757</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.434</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.342</ci_lower_limit>
            <ci_upper_limit>0.549</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.511</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.403</ci_lower_limit>
            <ci_upper_limit>0.647</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.708</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.560</ci_lower_limit>
            <ci_upper_limit>0.896</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.862</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.683</ci_lower_limit>
            <ci_upper_limit>1.088</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.755</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.597</ci_lower_limit>
            <ci_upper_limit>0.954</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.549</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.435</ci_lower_limit>
            <ci_upper_limit>0.692</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.646</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.511</ci_lower_limit>
            <ci_upper_limit>0.817</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>1.217</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.961</ci_lower_limit>
            <ci_upper_limit>1.541</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>1.066</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.841</ci_lower_limit>
            <ci_upper_limit>1.352</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.775</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.612</ci_lower_limit>
            <ci_upper_limit>0.981</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67.</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.912</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.719</ci_lower_limit>
            <ci_upper_limit>1.157</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.876</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.692</ci_lower_limit>
            <ci_upper_limit>1.109</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.637</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.504</ci_lower_limit>
            <ci_upper_limit>0.804</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.750</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.593</ci_lower_limit>
            <ci_upper_limit>0.949</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.727</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.574</ci_lower_limit>
            <ci_upper_limit>0.919</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>0.856</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.675</ci_lower_limit>
            <ci_upper_limit>1.084</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Two-sided 95% CI around the point estimates were to be presented for each endpoint.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 2-sided CIs were examined against a non-inferiority margin of 0.67</non_inferiority_desc>
            <param_type>Geometric mean ratio at day 43</param_type>
            <param_value>1.178</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.931</ci_lower_limit>
            <ci_upper_limit>1.489</ci_upper_limit>
            <estimate_desc>Pairwise Comparisons of GMTs (95% CI) Between Vaccination Groups at Day 43, on the pooled age groups.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Seroconversion and With HI ≥1:40, in Participants 18 to 60 Years of Age</title>
        <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP (Committee for Medicinal Products for Human Use) criteria. Seroconversion is defined as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as Hemagglutinin Inhibition (HI) antibody titer ≥1:40.</description>
        <time_frame>21 days after each vaccination</time_frame>
        <population>The analysis was on the per protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Seroconversion and With HI ≥1:40, in Participants 18 to 60 Years of Age</title>
          <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP (Committee for Medicinal Products for Human Use) criteria. Seroconversion is defined as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as Hemagglutinin Inhibition (HI) antibody titer ≥1:40.</description>
          <population>The analysis was on the per protocol set.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="130"/>
                <count group_id="O3" value="132"/>
                <count group_id="O4" value="132"/>
                <count group_id="O5" value="122"/>
                <count group_id="O6" value="124"/>
                <count group_id="O7" value="141"/>
                <count group_id="O8" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Seroprotection Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="118"/>
                    <measurement group_id="O3" value="126"/>
                    <measurement group_id="O4" value="125"/>
                    <measurement group_id="O5" value="116"/>
                    <measurement group_id="O6" value="121"/>
                    <measurement group_id="O7" value="140"/>
                    <measurement group_id="O8" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                    <measurement group_id="O2" value="95"/>
                    <measurement group_id="O3" value="116"/>
                    <measurement group_id="O4" value="118"/>
                    <measurement group_id="O5" value="111"/>
                    <measurement group_id="O6" value="113"/>
                    <measurement group_id="O7" value="129"/>
                    <measurement group_id="O8" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128"/>
                    <measurement group_id="O2" value="124"/>
                    <measurement group_id="O3" value="126"/>
                    <measurement group_id="O4" value="128"/>
                    <measurement group_id="O5" value="118"/>
                    <measurement group_id="O6" value="123"/>
                    <measurement group_id="O7" value="138"/>
                    <measurement group_id="O8" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                    <measurement group_id="O2" value="98"/>
                    <measurement group_id="O3" value="115"/>
                    <measurement group_id="O4" value="122"/>
                    <measurement group_id="O5" value="110"/>
                    <measurement group_id="O6" value="114"/>
                    <measurement group_id="O7" value="132"/>
                    <measurement group_id="O8" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Immunogenicity Results After Each Vaccination by Vaccine Group, in Participants ≥65 Years of Age</title>
        <description>Seroconversion is defined by CBER as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.</description>
        <time_frame>21 days after each vaccination</time_frame>
        <population>The analysis was on the per protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Immunogenicity Results After Each Vaccination by Vaccine Group, in Participants ≥65 Years of Age</title>
          <description>Seroconversion is defined by CBER as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as participants having HI antibody titer ≥1:40.</description>
          <population>The analysis was on the per protocol set.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="147"/>
                <count group_id="O3" value="164"/>
                <count group_id="O4" value="148"/>
                <count group_id="O5" value="159"/>
                <count group_id="O6" value="155"/>
                <count group_id="O7" value="154"/>
                <count group_id="O8" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Seroprotection Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                    <measurement group_id="O2" value="119"/>
                    <measurement group_id="O3" value="126"/>
                    <measurement group_id="O4" value="122"/>
                    <measurement group_id="O5" value="136"/>
                    <measurement group_id="O6" value="141"/>
                    <measurement group_id="O7" value="142"/>
                    <measurement group_id="O8" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="76"/>
                    <measurement group_id="O3" value="102"/>
                    <measurement group_id="O4" value="92"/>
                    <measurement group_id="O5" value="104"/>
                    <measurement group_id="O6" value="110"/>
                    <measurement group_id="O7" value="111"/>
                    <measurement group_id="O8" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131"/>
                    <measurement group_id="O2" value="116"/>
                    <measurement group_id="O3" value="132"/>
                    <measurement group_id="O4" value="131"/>
                    <measurement group_id="O5" value="126"/>
                    <measurement group_id="O6" value="136"/>
                    <measurement group_id="O7" value="143"/>
                    <measurement group_id="O8" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="75"/>
                    <measurement group_id="O3" value="103"/>
                    <measurement group_id="O4" value="95"/>
                    <measurement group_id="O5" value="94"/>
                    <measurement group_id="O6" value="106"/>
                    <measurement group_id="O7" value="113"/>
                    <measurement group_id="O8" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 202 (N=80,71,85,79,84,82,87,82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="52"/>
                    <measurement group_id="O5" value="55"/>
                    <measurement group_id="O6" value="45"/>
                    <measurement group_id="O7" value="63"/>
                    <measurement group_id="O8" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 202 (N=80,71,85,79,84,82,87,82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="30"/>
                    <measurement group_id="O4" value="31"/>
                    <measurement group_id="O5" value="35"/>
                    <measurement group_id="O6" value="27"/>
                    <measurement group_id="O7" value="38"/>
                    <measurement group_id="O8" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 387(N=84,87,98,86,106,93,89,99)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="55"/>
                    <measurement group_id="O4" value="57"/>
                    <measurement group_id="O5" value="67"/>
                    <measurement group_id="O6" value="55"/>
                    <measurement group_id="O7" value="65"/>
                    <measurement group_id="O8" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 387(N=84,87,98,86,106,93,89,99)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="33"/>
                    <measurement group_id="O5" value="37"/>
                    <measurement group_id="O6" value="30"/>
                    <measurement group_id="O7" value="47"/>
                    <measurement group_id="O8" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Seroconversion and With HI ≥1:40, in Participants ≥61 Years of Age</title>
        <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP criteria. Seroconversion is defined as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as Hemagglutinin Inhibition (HI) antibody titer ≥1:40.</description>
        <time_frame>21 days after each vaccination</time_frame>
        <population>The analysis was on the per protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Seroconversion and With HI ≥1:40, in Participants ≥61 Years of Age</title>
          <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP criteria. Seroconversion is defined as the percentage of participants with either a prevaccination HI titer &lt;1:10 and a post vaccination HI titer &gt; 40 or a pre-vaccination HI titer &gt; 10 and a minimum four-fold rise in post-vaccination HI antibody titer. Seroprotection is defined as Hemagglutinin Inhibition (HI) antibody titer ≥1:40.</description>
          <population>The analysis was on the per protocol set.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="161"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="174"/>
                <count group_id="O4" value="157"/>
                <count group_id="O5" value="178"/>
                <count group_id="O6" value="169"/>
                <count group_id="O7" value="162"/>
                <count group_id="O8" value="167"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Seroprotection Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130"/>
                    <measurement group_id="O2" value="127"/>
                    <measurement group_id="O3" value="135"/>
                    <measurement group_id="O4" value="131"/>
                    <measurement group_id="O5" value="153"/>
                    <measurement group_id="O6" value="155"/>
                    <measurement group_id="O7" value="149"/>
                    <measurement group_id="O8" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                    <measurement group_id="O2" value="81"/>
                    <measurement group_id="O3" value="109"/>
                    <measurement group_id="O4" value="100"/>
                    <measurement group_id="O5" value="120"/>
                    <measurement group_id="O6" value="121"/>
                    <measurement group_id="O7" value="117"/>
                    <measurement group_id="O8" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroprotection Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="125"/>
                    <measurement group_id="O3" value="142"/>
                    <measurement group_id="O4" value="140"/>
                    <measurement group_id="O5" value="143"/>
                    <measurement group_id="O6" value="150"/>
                    <measurement group_id="O7" value="150"/>
                    <measurement group_id="O8" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                    <measurement group_id="O2" value="81"/>
                    <measurement group_id="O3" value="111"/>
                    <measurement group_id="O4" value="102"/>
                    <measurement group_id="O5" value="110"/>
                    <measurement group_id="O6" value="117"/>
                    <measurement group_id="O7" value="120"/>
                    <measurement group_id="O8" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Ratio From Baseline, in Participants 18 to 60 Years of Age and ≥61 Years of Age</title>
        <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP criteria. Geometric Mean Ratio (GMR) of the hemagglutinin inhibition (HI)titers.</description>
        <time_frame>21 days after vaccination</time_frame>
        <population>The analysis was on the per protocol set. For this analysis, total subjects enrolled were stratified and randomized in two age groups, according to the CHMP criteria, 18 to 60 years and over 60 years of age.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Ratio From Baseline, in Participants 18 to 60 Years of Age and ≥61 Years of Age</title>
          <description>Immunogenicity evaluation after each vaccination by vaccine group according to CHMP criteria. Geometric Mean Ratio (GMR) of the hemagglutinin inhibition (HI)titers.</description>
          <population>The analysis was on the per protocol set. For this analysis, total subjects enrolled were stratified and randomized in two age groups, according to the CHMP criteria, 18 to 60 years and over 60 years of age.</population>
          <units>Geometric Mean Ratio</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="296"/>
                <count group_id="O2" value="289"/>
                <count group_id="O3" value="306"/>
                <count group_id="O4" value="289"/>
                <count group_id="O5" value="300"/>
                <count group_id="O6" value="293"/>
                <count group_id="O7" value="303"/>
                <count group_id="O8" value="294"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 22 (18-60y; N=135,130,132,132,122,124,141,127)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="15" upper_limit="26"/>
                    <measurement group_id="O2" value="15" lower_limit="11" upper_limit="20"/>
                    <measurement group_id="O3" value="23" lower_limit="17" upper_limit="31"/>
                    <measurement group_id="O4" value="33" lower_limit="25" upper_limit="44"/>
                    <measurement group_id="O5" value="40" lower_limit="30" upper_limit="54"/>
                    <measurement group_id="O6" value="36" lower_limit="27" upper_limit="49"/>
                    <measurement group_id="O7" value="44" lower_limit="33" upper_limit="58"/>
                    <measurement group_id="O8" value="47" lower_limit="35" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 43 (18-60y; N=135,130,132,132,122,124,141,127)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="16" upper_limit="27"/>
                    <measurement group_id="O2" value="15" lower_limit="11" upper_limit="20"/>
                    <measurement group_id="O3" value="22" lower_limit="17" upper_limit="28"/>
                    <measurement group_id="O4" value="33" lower_limit="25" upper_limit="43"/>
                    <measurement group_id="O5" value="31" lower_limit="23" upper_limit="40"/>
                    <measurement group_id="O6" value="33" lower_limit="25" upper_limit="44"/>
                    <measurement group_id="O7" value="40" lower_limit="31" upper_limit="51"/>
                    <measurement group_id="O8" value="37" lower_limit="28" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 22 (≥61yrs; N=161,159,174,157,178,169,162,167)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.11" lower_limit="4.8" upper_limit="7.78"/>
                    <measurement group_id="O2" value="4.65" lower_limit="3.65" upper_limit="5.94"/>
                    <measurement group_id="O3" value="7.46" lower_limit="5.91" upper_limit="9.41"/>
                    <measurement group_id="O4" value="8.63" lower_limit="6.75" upper_limit="11"/>
                    <measurement group_id="O5" value="8.37" lower_limit="6.64" upper_limit="11"/>
                    <measurement group_id="O6" value="9.6" lower_limit="7.57" upper_limit="12"/>
                    <measurement group_id="O7" value="11" lower_limit="9.04" upper_limit="15"/>
                    <measurement group_id="O8" value="10" lower_limit="7.97" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 43 (≥61 yrs;N=161,159,174,157,178,169,162,167)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" lower_limit="4.97" upper_limit="7.75"/>
                    <measurement group_id="O2" value="4.18" lower_limit="3.34" upper_limit="5.23"/>
                    <measurement group_id="O3" value="6.77" lower_limit="5.47" upper_limit="8.4"/>
                    <measurement group_id="O4" value="7.78" lower_limit="6.21" upper_limit="9.75"/>
                    <measurement group_id="O5" value="6.72" lower_limit="5.43" upper_limit="8.31"/>
                    <measurement group_id="O6" value="7.78" lower_limit="6.25" upper_limit="9.68"/>
                    <measurement group_id="O7" value="11" lower_limit="8.76" upper_limit="14"/>
                    <measurement group_id="O8" value="8.8" lower_limit="7.07" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the First Vaccination, in Participants 18 to 64 Years of Age</title>
        <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
        <time_frame>7 days after vaccination</time_frame>
        <population>The population used in analysis was the safety set</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the First Vaccination, in Participants 18 to 64 Years of Age</title>
          <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
          <population>The population used in analysis was the safety set</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="170"/>
                <count group_id="O4" value="165"/>
                <count group_id="O5" value="170"/>
                <count group_id="O6" value="168"/>
                <count group_id="O7" value="173"/>
                <count group_id="O8" value="168"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="51"/>
                    <measurement group_id="O4" value="78"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="57"/>
                    <measurement group_id="O7" value="78"/>
                    <measurement group_id="O8" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="79"/>
                    <measurement group_id="O5" value="42"/>
                    <measurement group_id="O6" value="64"/>
                    <measurement group_id="O7" value="89"/>
                    <measurement group_id="O8" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="29"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="30"/>
                    <measurement group_id="O7" value="37"/>
                    <measurement group_id="O8" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="43"/>
                    <measurement group_id="O6" value="39"/>
                    <measurement group_id="O7" value="36"/>
                    <measurement group_id="O8" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting (N=169, 168, 169, 165, 170, 168, 173,168)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhoea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="27"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oral Temp. (≥40°C)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stay Home</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the Second Vaccination, in Participants 18 to 64 Years of Age</title>
        <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
        <time_frame>7 days after vaccination</time_frame>
        <population>The analysis was on the safety set.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the Second Vaccination, in Participants 18 to 64 Years of Age</title>
          <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
          <population>The analysis was on the safety set.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
                <count group_id="O2" value="163"/>
                <count group_id="O3" value="162"/>
                <count group_id="O4" value="160"/>
                <count group_id="O5" value="162"/>
                <count group_id="O6" value="160"/>
                <count group_id="O7" value="169"/>
                <count group_id="O8" value="163"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="39"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="35"/>
                    <measurement group_id="O6" value="43"/>
                    <measurement group_id="O7" value="54"/>
                    <measurement group_id="O8" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling (N=164,163,162,160,162,160,169,162)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="52"/>
                    <measurement group_id="O4" value="56"/>
                    <measurement group_id="O5" value="44"/>
                    <measurement group_id="O6" value="58"/>
                    <measurement group_id="O7" value="66"/>
                    <measurement group_id="O8" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="16"/>
                    <measurement group_id="O7" value="24"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache(N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="32"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea(N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhoea(N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue(N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="18"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oral Temp ≥40°C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stay Home (N=164,163,161,160,162,159,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analg/antipyr (N=164,163,162,160,162,160,169,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the First Vaccination, in Participants ≥65 Years of Age</title>
        <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
        <time_frame>7 days after vaccination</time_frame>
        <population>The analysis was on the safety set.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the First Vaccination, in Participants ≥65 Years of Age</title>
          <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
          <population>The analysis was on the safety set.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="170"/>
                <count group_id="O2" value="166"/>
                <count group_id="O3" value="173"/>
                <count group_id="O4" value="169"/>
                <count group_id="O5" value="169"/>
                <count group_id="O6" value="171"/>
                <count group_id="O7" value="169"/>
                <count group_id="O8" value="167"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="30"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="27"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="24"/>
                    <measurement group_id="O6" value="28"/>
                    <measurement group_id="O7" value="39"/>
                    <measurement group_id="O8" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="22"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomitting (N=170,166,173,169.169,170,169,167)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhoea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="22"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oral Temp ≥40°C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stay Home</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analg/antipyr (N=170,166,172,169.167,171,169,166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the Second Vaccination, in Participants ≥65 Years of Age</title>
        <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
        <time_frame>7 days after vaccination</time_frame>
        <population>The analysis was on the safety set.</population>
        <group_list>
          <group group_id="O1">
            <title>3.75_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 3.75 µg A/H1N1 antigen administered on day 1 and day 22</description>
          </group>
          <group group_id="O2">
            <title>7.5 w/o MF59</title>
            <description>1 dose of 7.5 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O3">
            <title>7.5_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O4">
            <title>7.5_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 7.5 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O5">
            <title>15 w/o MF59</title>
            <description>1 dose of 15 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
          <group group_id="O6">
            <title>15_(50)MF59</title>
            <description>50% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O7">
            <title>15_(100)MF59</title>
            <description>100% of MF59 (an adjuvant) with 15 µg A/H1N1 antigen administered on study day 1 and day 22</description>
          </group>
          <group group_id="O8">
            <title>30 w/o MF59</title>
            <description>1 dose of 30 µg A/H1N1 administered on study day 1 and day 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Solicited Local and Systemic Reactions After the Second Vaccination, in Participants ≥65 Years of Age</title>
          <description>Solicited local and systemic reactions that occurred within 7 days after the day of vaccination were used as indicators of reactogenicity.</description>
          <population>The analysis was on the safety set.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
                <count group_id="O2" value="156"/>
                <count group_id="O3" value="171"/>
                <count group_id="O4" value="160"/>
                <count group_id="O5" value="166"/>
                <count group_id="O6" value="168"/>
                <count group_id="O7" value="165"/>
                <count group_id="O8" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain (N=164,156,171,160,166,168,165,165)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness (N=164,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="30"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="26"/>
                    <measurement group_id="O7" value="31"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting (N=164,156,171,160,166,168,165,165)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhoea (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue (N=163,156,171,160,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oral Temp≥40°C (N=164,156,171,160,166,168,165,165)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stay Home(N=163,156,171,159,166,168,165,164)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analg/antipyr (N=164,156,171,160,166,167,165,163)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All solicited AEs were collected for the first 3 weeks after each vaccination. SAEs, new onset of chronic diseases, AEs that led to withdrawal from study and AEs associated with medically attended visits, were collected for the whole study (days 1-387).</time_frame>
      <desc>A systematic AE is equivalent to an event that was solicited by the diary card, while a non-systematic event is equivalent to an event not solicited by the diary card. Safety was analyzed with data from all study centers; 10 enrolled participants were excluded for not receiving study vaccine or not providing safety data after first vaccination.</desc>
      <group_list>
        <group group_id="E1">
          <title>3.75_(50)MF59</title>
          <description>50% of MF59 with the lowest amount of A/H1N1 antigen</description>
        </group>
        <group group_id="E2">
          <title>7.5 w/o MF59</title>
          <description>1 dose of 7.5 µg A/H1N1</description>
        </group>
        <group group_id="E3">
          <title>7.5_(50)MF59</title>
          <description>50% of MF59 with 7.5 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E4">
          <title>7.5_(100)MF59</title>
          <description>100% of MF59 with 7.5 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E5">
          <title>15 w/o MF59</title>
          <description>1 dose of 15 µg A/H1N1</description>
        </group>
        <group group_id="E6">
          <title>15_(50)MF59</title>
          <description>50% of MF59 with 15 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E7">
          <title>15_(100)MF59</title>
          <description>100% of MF59 with 15 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E8">
          <title>30 w/o MF59</title>
          <description>1 dose of 30 µg A/H1N1</description>
        </group>
        <group group_id="E9">
          <title>3.75_(50)MF59 (Above 65 Yrs)</title>
          <description>50% of MF59 with the lowest amount of A/H1N1 antigen</description>
        </group>
        <group group_id="E10">
          <title>7.5 w/o MF59 (≥65 Yrs)</title>
          <description>1 dose of 7.5 µg A/H1N1</description>
        </group>
        <group group_id="E11">
          <title>7.5_(50)MF59 (≥65 Yrs)</title>
          <description>50% of MF59 with 7.5 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E12">
          <title>7.5_(100)MF59 (≥65 Yrs)</title>
          <description>100% of MF59 with 7.5 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E13">
          <title>15 w/o MF59 (≥ 65 Yrs)</title>
          <description>1 dose of 15 µg A/H1N1</description>
        </group>
        <group group_id="E14">
          <title>15_(50)MF59 (≥65 Yrs)</title>
          <description>50% of MF59 with 15 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E15">
          <title>15_(100)MF59 (≥65 Yrs)</title>
          <description>100% of MF59 with 15 µg A/H1N1 antigen</description>
        </group>
        <group group_id="E16">
          <title>30 w/o MF59 (≥65 Yrs)</title>
          <description>1 dose of 30 µg A/H1N1</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="9" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="16" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="18" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="11" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="20" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="14" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="10" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Aortic Valve imcompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Colitis Ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Colitis Ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Intestinal Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Intestinal Obstructuction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Suicide Attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gallbladder non-functioning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Biliary Colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Gallbladder Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Lobar Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cholecystitis Infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>H1N1 Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Incisional Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Splenic Rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Traumatic Lung Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Arthropod Bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Head Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Scapula Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Skin Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Traumatic Brain Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Urinary Retention Postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Pressure Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Glucose Tolerance Impaired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Arthritis Reactive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Spinal Column Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Synovial Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acoustic Neuroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>B-Cell Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Gallbladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Penis Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Breast Cancer Stage I</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Lung Carcinoma Cell Type Unspecified Stage I</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Parathyroid Tumour Benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Thyroid Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Uterine Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Viith Nerve Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Carotid Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cerebral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Grand Mal Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Subarachnoid Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion Spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Abortion Spontaneus Complete</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Eclampsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Suicidal Ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Menstruation Irregular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Prostatic Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Tonsillar Hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Intestinal Resection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Ankle Operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Knee Arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Intra-abdominal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Hypertensive Emergency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="125" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="108" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="121" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="128" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="113" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="122" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="130" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="110" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="102" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="88" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="101" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="118" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="104" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="109" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="97" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="99" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="27" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="17" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="10" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="11" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="9" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="15" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="17" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="22" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="16" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="13" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="17" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="16" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="9" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="97" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="90" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="109" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="72" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="102" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="112" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="80" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="42" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="23" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="42" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="60" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="51" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="57" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="50" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="47" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="31" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="31" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="37" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="36" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="31" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="36" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="24" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="29" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="23" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="26" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="19" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="28" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="17" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="23" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="13" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="15" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="12" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="15" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="22" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="16" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="14" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="23" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="21" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="14" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="20" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="17" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="11" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="11" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="10" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="15" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="20" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="15" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="13" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="6" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="12" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="15" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="15" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="11" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="12" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="8" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="10" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="5" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="13" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="13" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="7" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract infection</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="8" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="11" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="43" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="32" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="39" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="47" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="30" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="35" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="24" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="27" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="27" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="26" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="23" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="27" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="19" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="13" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="29" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="18" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="21" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="23" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="16" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="17" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="21" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="14" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Pain in Extremity</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="12" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="51" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="42" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="60" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="55" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="50" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="43" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="33" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="29" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="33" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="30" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="28" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="29" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="25" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="24" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="5" subjects_at_risk="167"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="170"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="171"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="165"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="170"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="174"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="168"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="170"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="166"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="173"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="169"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="169"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="171"/>
                <counts group_id="E15" subjects_affected="11" subjects_at_risk="169"/>
                <counts group_id="E16" subjects_affected="9" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Posting Director</name_or_title>
      <organization>Novartis Vaccines and Diagnostics</organization>
      <email>RegContactVacUS.nvdit@Novartis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

